MoneyWorks4Me

Medicamen Biotech - Quaterly Results

12 Aug 2025 Evaluate
Net sales declined -7.31%  to  Rs. 384.49 million from Rs. 414.82 millions.Net profit declined -27.51% to Rs. 16.36 millions from Rs. 22.57 millions.A decline of 45.04 millions was observed in the OP in the quarter ended June 2025 from 54.35 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 384.49 414.82 -7.31 384.49 414.82 -7.31 1514.63 1723.86 -12.14
Other Income 4.70 5.75 -18.26 4.70 5.75 -18.26 62.25 23.03 170.30
PBIDT 45.04 54.35 -17.13 45.04 54.35 -17.13 227.83 282.74 -19.42
Interest 5.62 6.78 -17.11 5.62 6.78 -17.11 30.45 43.77 -30.43
PBDT 39.42 47.57 -17.13 39.42 47.57 -17.13 197.38 238.97 -17.40
Depreciation 17.73 17.42 1.78 17.73 17.42 1.78 69.53 70.08 -0.78
PBT 21.69 30.15 -28.06 21.69 30.15 -28.06 127.85 168.89 -24.30
TAX 5.33 7.58 -29.68 5.33 7.58 -29.68 33.24 35.90 -7.41
Deferred Tax -0.37 -0.78 -52.56 -0.37 -0.78 -52.56 -3.15 -6.27 -49.76
PAT 16.36 22.57 -27.51 16.36 22.57 -27.51 94.61 132.99 -28.86
Equity 135.63 127.15 6.67 135.63 127.15 6.67 127.15 127.15 0.00
PBIDTM(%) 11.71 13.10 -10.59 11.71 13.10 -10.59 15.04 16.40 -8.29
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..